Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 60 | Issue 2s | pp. s617–s626Open access
Combined Raft Formation-Interpenetrating Complex Approach to Reconstitutable Sustained-Release Suspension Development
- 1,
- 1*,
- 2,
- 3,
- 2
- 1 Department of Pharmaceutics, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, INDIA.
- 2 Department of Pharmacognosy, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, INDIA.
- 3 Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Dilesh Jagdish Singhavi
Department of Pharmaceutics, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, INDIA.
Email: dileshsinghavi@rediffmail.com
- Received:
- Nov 12, 2025
- Accepted:
- Feb 3, 2026
- DOI:
- 10.5530/ijper.20261811
How to cite
Chandewar, P. A., Singhavi, D. J., Gedam, P. P., Karande, N. A., & Ganjiwale, R. O. Combined Raft Formation-Interpenetrating Complex Approach to Reconstitutable Sustained-Release Suspension Development. Indian Journal of Pharmaceutical Education and Research, 60(2s), s617–s626. https://doi.org/10.5530/ijper.20261811
Abstract
Background: The foundation of this work is the use of raft formation and Interpenetrating Polymeric Network (IPN) complexation techniques to create a reconstitutable sustained-release suspension of Diltiazem Hydrochloride (DZH) for elderly patients. Materials and Methods: Xanthan gum and chitosan were used in combination to prepare IPN complexes of DZH. A central composite design was used to optimize the raft-forming in situ gelling system. The concentrations of HPMC K4M and sodium alginate were the independent variables. Results: In vitro dissolution, X-ray powder diffraction, and differential scanning calorimetric studies were conducted to examine the IPN complexes. The optimized batch (ratio of sodium alginate to HPMC K4M, 1500:100) exhibited gelation properties for an extended time period, as well as the desirable floating duration (>12 hr). A desirable drug release of 97.39±0.97% in up to 12 hr was achieved. The release kinetics of the DZH obeyed the Higuchi order of release following the Fickian diffusion mechanism with an n value of 0.366. Conclusion: The in vitro study suggested that a reconstitutable sustained-release suspension was successfully prepared using the raft forming formulation approach and the IPN complex of DZH. The optimized formulation exhibited sustained release of the water-soluble drug over 12 hr due to the combined effect of the RFGS and the IPN complex.
Keywords
Subject
Article metadata
| Title | Combined Raft Formation-Interpenetrating Complex Approach to Reconstitutable Sustained-Release Suspension Development |
|---|---|
| Authors | Pallavi Asaram Chandewar; Dilesh Jagdish Singhavi; Prachi Pradiprao Gedam; Nilesh Ashok Karande; Rajendra Onkarappa Ganjiwale |
| Affiliations | Department of Pharmaceutics, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, INDIA.; Department of Pharmacognosy, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, INDIA.; Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, Maharashtra, INDIA. |
| Corresponding author | dileshsinghavi@rediffmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 60, Issue 2s |
Also in this issue
- Artificial Intelligence/Machine Learning in Pharma Analysis and Quality Control: A Real-World Upgradepp. s375–s384
- Emerging Dynamics of the Medical Devices Sector in Indiapp. s385–s410
- Herbal Medicine in Gynecological and Obstetric Care: A Comprehensive Review of Clinical Trialspp. s411–s429
- Quality by Design (QbD) Approach in the Formulation of Liposomal Gel: A Reviewpp. s430–s435
- Fabrication of Microneedle Patches of Indomethacin Using 3DP Technologypp. s436–s442